Vault-13

PERCEPTIVE ADVISORS LLC

NEW YORK, NY · CIK 1224962 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2010 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 25
Greenwich, CTUnited States United States1
Miami Beach, FLUnited States United States1
Sheridan, WYUnited States United States1
Water Mill, NYUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$3.2bn reported value -36.3% vs Q1 2022
109positions
52.9%in top 10
9 new 15 added 47 reduced 35 sold out vs Q1 2022

Options: 0 call positions (— notional), 2 put positions ($10.2m notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TRAVERE THERAPEUTICS INC NOTE 2.250% 3/0 · principal TVTX 2.25 03.01.29 · principal TVTX 2.25 03.01.29 45,000,000 $455.9m14.33% 14.33% UnchangedPrincipal held: Q3 2021 0, Q4 2021 0, Q1 2022 45.0m, Q2 2022 45.0m
2 AMICUS THERAPEUTICS INC COM FOLD FOLD 26,895,532 $288.9m9.08% 9.08% ReducedShares held: Q3 2021 26.6m, Q4 2021 53.1m, Q1 2022 27.6m, Q2 2022 26.9m -660.3k -660,313 -2.4%
3 MIRATI THERAPEUTICS INC COM MRTX MRTX 2,866,863 $192.5m6.05% 6.05% AddedShares held: Q3 2021 3.4m, Q4 2021 6.6m, Q1 2022 2.4m, Q2 2022 2.9m +486.2k +486,153 20.4%
4 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 5,086,727 $134.5m4.23% 4.23% UnchangedShares held: Q3 2021 5.1m, Q4 2021 10.2m, Q1 2022 5.1m, Q2 2022 5.1m
5 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 11,826,299 $130.6m4.10% 4.10% ReducedShares held: Q3 2021 11.5m, Q4 2021 20.3m, Q1 2022 12.2m, Q2 2022 11.8m -375.0k -374,962 -3.1%
6 LIANBIO SPONSORED ADS LIANY LIANY 56,560,211 $122.2m3.84% 3.84% AddedShares held: Q3 2021 0, Q4 2021 112.6m, Q1 2022 56.3m, Q2 2022 56.6m +240.3k +240,251 0.4%
7 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 5,321,032 $99.2m3.12% 3.12% AddedShares held: Q3 2021 4.0m, Q4 2021 10.3m, Q1 2022 5.2m, Q2 2022 5.3m +157.5k +157,515 3.0%
8 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 3,015,054 $96.3m3.03% 3.03% ReducedShares held: Q3 2021 4.4m, Q4 2021 6.9m, Q1 2022 3.9m, Q2 2022 3.0m -877.4k -877,439 -22.5%
9 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 3,867,446 $95.2m2.99% 2.99% ReducedShares held: Q3 2021 4.8m, Q4 2021 9.7m, Q1 2022 4.5m, Q2 2022 3.9m -660.5k -660,547 -14.6%
10 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 3,540,408 $68.2m2.14% 2.14% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.5m, Q2 2022 3.5m +2.1m +2,066,301 140.2%
11 XENON PHARMACEUTICALS INC COM XENE XENE 2,122,535 $64.6m2.03% 2.03% ReducedShares held: Q3 2021 2.0m, Q4 2021 4.8m, Q1 2022 2.4m, Q2 2022 2.1m -288.9k -288,912 -12.0%
12 MEIRAGTX HLDGS PLC COM MGTX MGTX 6,963,277 $52.7m1.66% 1.66% AddedShares held: Q3 2021 6.9m, Q4 2021 13.9m, Q1 2022 6.9m, Q2 2022 7.0m +15.0k +15,000 0.2%
13 LYRA THERAPEUTICS INC COM LYRA LYRA 9,146,730 $51.7m1.62% 1.62% AddedShares held: Q3 2021 3.2m, Q4 2021 6.4m, Q1 2022 3.2m, Q2 2022 9.1m +5.9m +5,924,170 183.8%
14 BELLUS HEALTH INC NEW COM NEW BLU BLU 5,534,169 $51.1m1.61% 1.61% ReducedShares held: Q3 2021 0, Q4 2021 15.3m, Q1 2022 8.1m, Q2 2022 5.5m -2.6m -2,602,461 -32.0%
15 PROMETHEUS BIOSCIENCES INC COM COM 1,682,242 $47.5m1.49% 1.49% ReducedShares held: Q3 2021 3.3m, Q4 2021 6.3m, Q1 2022 2.4m, Q2 2022 1.7m -758.3k -758,340 -31.1%
16 ALBIREO PHARMA INC COM BIOD BIOD 2,360,139 $46.9m1.47% 1.47% UnchangedShares held: Q3 2021 2.4m, Q4 2021 4.7m, Q1 2022 2.4m, Q2 2022 2.4m
17 CINCOR PHARMA INC COM COM 2,319,117 $43.7m1.37% 1.37% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 2.3m, Q2 2022 2.3m
18 VBI VACCINES INC CDA COM NEW COM NEW 52,335,002 $42.3m1.33% 1.33% UnchangedShares held: Q3 2021 55.0m, Q4 2021 104.7m, Q1 2022 52.3m, Q2 2022 52.3m
19 SEAGEN INC COM SGEN SGEN 224,000 $39.6m1.25% 1.25% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 224.0k
20 VERU INC COM COM 3,500,000 $39.5m1.24% 1.24% ReducedShares held: Q3 2021 4.5m, Q4 2021 8.9m, Q1 2022 4.4m, Q2 2022 3.5m -862.0k -861,998 -19.8%
21 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 9,903,879 $39.5m1.24% 1.24% UnchangedShares held: Q3 2021 9.9m, Q4 2021 19.8m, Q1 2022 9.9m, Q2 2022 9.9m
22 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 397,888 $38.8m1.22% 1.22% AddedShares held: Q3 2021 483.0k, Q4 2021 966.0k, Q1 2022 395.6k, Q2 2022 397.9k +2.2k +2,249 0.6%
23 RAPT THERAPEUTICS INC COM COM 1,913,791 $34.9m1.10% 1.10% ReducedShares held: Q3 2021 2.9m, Q4 2021 5.9m, Q1 2022 2.8m, Q2 2022 1.9m -886.2k -886,171 -31.6%
24 RELAY THERAPEUTICS INC COM RLAY RLAY 1,943,097 $32.5m1.02% 1.02% UnchangedShares held: Q3 2021 1.9m, Q4 2021 3.9m, Q1 2022 1.9m, Q2 2022 1.9m
25 ELI LILLY & CO COM LLY LLY 100,000 $32.4m1.02% 1.02% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 100.0k
26 COHERUS BIOSCIENCES INC NOTE 1.500% 4/1 · principal CHRS 1.5 04.15.26 · principal CHRS 1.5 04.15.26 4,500,000 $29.5m0.93% 0.93% UnchangedPrincipal held: Q3 2021 4.5m, Q4 2021 9.0m, Q1 2022 4.5m, Q2 2022 4.5m
27 COGENT BIOSCIENCES INC COM COGT COGT 3,088,972 $27.9m0.88% 0.88% ReducedShares held: Q3 2021 3.2m, Q4 2021 6.4m, Q1 2022 3.2m, Q2 2022 3.1m -99.8k -99,778 -3.1%
28 COHERUS BIOSCIENCES INC COM CHRS CHRS 3,645,471 $26.4m0.83% 0.83% ReducedShares held: Q3 2021 4.8m, Q4 2021 10.8m, Q1 2022 4.7m, Q2 2022 3.6m -1.1m -1,050,377 -22.4%
29 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 367,501 $26.3m0.83% 0.83% AddedShares held: Q3 2021 0, Q4 2021 172.8k, Q1 2022 278.3k, Q2 2022 367.5k +89.2k +89,215 32.1%
30 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 172,991 $25.2m0.79% 0.79% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 180.1k, Q2 2022 173.0k -7.1k -7,088 -3.9%
31 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 9,111,151 $24.5m0.77% 0.77% UnchangedShares held: Q3 2021 8.9m, Q4 2021 18.2m, Q1 2022 9.1m, Q2 2022 9.1m
32 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 749,700 $24.5m0.77% 0.77% ReducedShares held: Q3 2021 1.7m, Q4 2021 2.7m, Q1 2022 1.5m, Q2 2022 749.7k -738.6k -738,584 -49.6%
33 ADMA BIOLOGICS INC COM ADMA ADMA 11,521,102 $22.8m0.72% 0.72% ReducedShares held: Q3 2021 13.3m, Q4 2021 23.9m, Q1 2022 11.9m, Q2 2022 11.5m -412.3k -412,285 -3.5%
34 NUVALENT INC COM COM 1,655,007 $22.4m0.71% 0.71% ReducedShares held: Q3 2021 750.0k, Q4 2021 1.5m, Q1 2022 1.8m, Q2 2022 1.7m -96.6k -96,594 -5.5%
35 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 405,759 $22.1m0.69% 0.69% ReducedShares held: Q3 2021 505.5k, Q4 2021 811.1k, Q1 2022 450.4k, Q2 2022 405.8k -44.6k -44,615 -9.9%
36 ZYMEWORKS INC COM ZYME ZYME 4,132,534 $21.9m0.69% 0.69% ReducedShares held: Q3 2021 3.7m, Q4 2021 7.4m, Q1 2022 5.3m, Q2 2022 4.1m -1.2m -1,193,081 -22.4%
37 IMMATICS N.V SHS IMTX IMTX 2,500,000 $21.8m0.68% 0.68% UnchangedShares held: Q3 2021 2.5m, Q4 2021 5.0m, Q1 2022 2.5m, Q2 2022 2.5m
38 INHIBRX INC COM INBX INBX 1,914,592 $21.7m0.68% 0.68% AddedShares held: Q3 2021 1.1m, Q4 2021 2.7m, Q1 2022 1.8m, Q2 2022 1.9m +133.4k +133,357 7.5%
39 ARCELLX INC COMMON STOCK ACLX ACLX 1,141,990 $20.6m0.65% 0.65% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.1m
40 IVERIC BIO INC COM OPHT OPHT 2,087,956 $20.1m0.63% 0.63% ReducedShares held: Q3 2021 7.5m, Q4 2021 13.0m, Q1 2022 5.2m, Q2 2022 2.1m -3.1m -3,137,459 -60.0%
41 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 411,804 $20.1m0.63% 0.63% NewShares held: Q3 2021 491.3k, Q4 2021 478.5k, Q1 2022 0, Q2 2022 411.8k
42 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,296,416 $18.9m0.59% 0.59% UnchangedShares held: Q3 2021 1.3m, Q4 2021 2.6m, Q1 2022 1.3m, Q2 2022 1.3m
43 ARTIVION INC COM AORT AORT 929,705 $17.6m0.55% 0.55% AddedShares held: Q3 2021 0, Q4 2021 652.6k, Q1 2022 615.7k, Q2 2022 929.7k +314.0k +314,002 51.0%
44 DICE THERAPEUTICS INC COM COM 1,051,904 $16.3m0.51% 0.51% ReducedShares held: Q3 2021 0, Q4 2021 1.4m, Q1 2022 1.5m, Q2 2022 1.1m -463.5k -463,457 -30.6%
45 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 1,166,883 $16.1m0.50% 0.50% ReducedShares held: Q3 2021 2.3m, Q4 2021 3.9m, Q1 2022 1.7m, Q2 2022 1.2m -511.2k -511,207 -30.5%
46 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,697,033 $15.4m0.48% 0.48% ReducedShares held: Q3 2021 7.8m, Q4 2021 14.3m, Q1 2022 3.8m, Q2 2022 1.7m -2.1m -2,142,347 -55.8%
47 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 180,000 $14.9m0.47% 0.47% NewShares held: Q3 2021 0, Q4 2021 2.4m, Q1 2022 0, Q2 2022 180.0k
48 OUTSET MED INC COM OM OM 998,727 $14.8m0.47% 0.47% ReducedShares held: Q3 2021 2.0m, Q4 2021 3.7m, Q1 2022 1.9m, Q2 2022 998.7k -884.7k -884,672 -47.0%
49 ATHIRA PHARMA INC COM COM 4,797,278 $14.6m0.46% 0.46% AddedShares held: Q3 2021 3.4m, Q4 2021 6.9m, Q1 2022 3.4m, Q2 2022 4.8m +1.4m +1,371,362 40.0%
50 APELLIS PHARMACEUTICALS INC COM APLS APLS 321,300 $14.5m0.46% 0.46% ReducedShares held: Q3 2021 615.0k, Q4 2021 2.9m, Q1 2022 1.5m, Q2 2022 321.3k -1.2m -1,160,400 -78.3%
51 TRAVERE THERAPEUTICS INC COM TVTX TVTX 570,084 $13.8m0.43% 0.43% ReducedShares held: Q3 2021 2.0m, Q4 2021 3.7m, Q1 2022 1.8m, Q2 2022 570.1k -1.3m -1,275,471 -69.1%
52 RAIN ONCOLOGY INC COM COM 2,483,619 $13.8m0.43% 0.43% UnchangedShares held: Q3 2021 2.5m, Q4 2021 5.0m, Q1 2022 2.5m, Q2 2022 2.5m
53 SINGULAR GENOMICS SYSTEMS IN COM COM 3,536,274 $13.5m0.42% 0.42% ReducedShares held: Q3 2021 3.1m, Q4 2021 6.7m, Q1 2022 3.7m, Q2 2022 3.5m -118.9k -118,933 -3.2%
54 TREACE MED CONCEPTS INC COM TMCI TMCI 941,192 $13.5m0.42% 0.42% ReducedShares held: Q3 2021 1.2m, Q4 2021 2.0m, Q1 2022 971.2k, Q2 2022 941.2k -30.0k -30,000 -3.1%
55 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 2,915,146 $12.2m0.38% 0.38% ReducedShares held: Q3 2021 2.9m, Q4 2021 5.7m, Q1 2022 3.0m, Q2 2022 2.9m -129.2k -129,157 -4.2%
56 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 971,832 $11.2m0.35% 0.35% ReducedShares held: Q3 2021 1.4m, Q4 2021 2.8m, Q1 2022 1.4m, Q2 2022 971.8k -451.2k -451,221 -31.7%
57 CHEMOCENTRYX INC COM CCXI CCXI 441,680 $10.9m0.34% 0.34% ReducedShares held: Q3 2021 550.0k, Q4 2021 2.8m, Q1 2022 1.7m, Q2 2022 441.7k -1.2m -1,213,399 -73.3%
58 CAREMAX INC COM CL A COM CL A 3,000,000 $10.9m0.34% 0.34% ReducedShares held: Q3 2021 3.4m, Q4 2021 7.1m, Q1 2022 3.2m, Q2 2022 3.0m -186.7k -186,663 -5.9%
59 LANDOS BIOPHARMA INC COM COM 14,869,915 $10.8m0.34% 0.34% UnchangedShares held: Q3 2021 14.9m, Q4 2021 29.7m, Q1 2022 14.9m, Q2 2022 14.9m
60 DAY ONE BIOPHARMACEUTICALS I COM COM 556,047 $10.0m0.31% 0.31% UnchangedShares held: Q3 2021 556.0k, Q4 2021 1.1m, Q1 2022 556.0k, Q2 2022 556.0k
61 VERRICA PHARMACEUTICALS INC COM COM 5,038,983 $9.7m0.30% 0.30% AddedShares held: Q3 2021 3.6m, Q4 2021 7.2m, Q1 2022 3.6m, Q2 2022 5.0m +1.4m +1,428,571 39.6%
62 LEAP THERAPEUTICS INC COM LPTX LPTX 7,951,448 $9.1m0.29% 0.29% UnchangedShares held: Q3 2021 8.5m, Q4 2021 17.0m, Q1 2022 8.0m, Q2 2022 8.0m
63 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 2,150,641 $9.1m0.28% 0.28% UnchangedShares held: Q3 2021 2.2m, Q4 2021 4.3m, Q1 2022 2.2m, Q2 2022 2.2m
64 ISOPLEXIS CORP COM COM 4,095,498 $8.8m0.28% 0.28% UnchangedShares held: Q3 2021 0, Q4 2021 8.2m, Q1 2022 4.1m, Q2 2022 4.1m
65 KRONOS BIO INC COM KRON KRON 2,421,142 $8.8m0.28% 0.28% UnchangedShares held: Q3 2021 2.4m, Q4 2021 4.8m, Q1 2022 2.4m, Q2 2022 2.4m
66 HILLEVAX INC COM COM 764,907 $8.4m0.26% 0.26% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 764.9k
67 SOLID BIOSCIENCES INC COM COM 13,412,552 $8.3m0.26% 0.26% UnchangedShares held: Q3 2021 13.4m, Q4 2021 26.8m, Q1 2022 13.4m, Q2 2022 13.4m
68 PRIVIA HEALTH GROUP INC COM PRVA PRVA 273,423 $8.0m0.25% 0.25% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 213.4k, Q2 2022 273.4k +60.0k +60,000 28.1%
69 REVANCE THERAPEUTICS INC COM RVNC RVNC 572,514 $7.9m0.25% 0.25% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 137.5k, Q2 2022 572.5k +435.0k +435,000 316.3%
70 MORPHIC HLDG INC COM MORF MORF 363,197 $7.9m0.25% 0.25% ReducedShares held: Q3 2021 887.3k, Q4 2021 1.7m, Q1 2022 767.3k, Q2 2022 363.2k -404.1k -404,130 -52.7%
71 POINT BIOPHARMA GLOBAL INC COM COM 1,073,995 $7.3m0.23% 0.23% ReducedShares held: Q3 2021 1.2m, Q4 2021 2.4m, Q1 2022 1.2m, Q2 2022 1.1m -120.0k -120,000 -10.1%
72 SOMALOGIC INC CLASS A COM SLGC SLGC 1,500,000 $6.8m0.21% 0.21% UnchangedShares held: Q3 2021 2.0m, Q4 2021 3.0m, Q1 2022 1.5m, Q2 2022 1.5m
73 HEALTH CATALYST INC COM HCAT HCAT 465,162 $6.7m0.21% 0.21% ReducedShares held: Q3 2021 589.0k, Q4 2021 908.0k, Q1 2022 493.7k, Q2 2022 465.2k -28.5k -28,500 -5.8%
74 SEMA4 HOLDINGS CORP COM CL A SMFR SMFR 5,000,000 $6.3m0.20% 0.20% AddedShares held: Q3 2021 2.5m, Q4 2021 5.0m, Q1 2022 2.5m, Q2 2022 5.0m +2.5m +2,500,000 100.0%
75 ICOSAVAX INC COM COM 1,042,850 $6.0m0.19% 0.19% ReducedShares held: Q3 2021 1.9m, Q4 2021 3.8m, Q1 2022 1.4m, Q2 2022 1.0m -336.3k -336,287 -24.4%
76 C4 THERAPEUTICS INC COM STK CCCC CCCC 766,231 $5.8m0.18% 0.18% ReducedShares held: Q3 2021 2.3m, Q4 2021 4.4m, Q1 2022 2.1m, Q2 2022 766.2k -1.3m -1,316,492 -63.2%
77 NUVATION BIO INC COM CL A NUVB NUVB 1,769,701 $5.7m0.18% 0.18% UnchangedShares held: Q3 2021 3.0m, Q4 2021 5.8m, Q1 2022 1.8m, Q2 2022 1.8m
78 ATHENEX INC COM ATNX ATNX 13,532,467 $5.5m0.17% 0.17% UnchangedShares held: Q3 2021 13.5m, Q4 2021 27.1m, Q1 2022 13.5m, Q2 2022 13.5m
79 ACLARIS THERAPEUTICS INC COM ACRS ACRS 341,239 $4.8m0.15% 0.15% ReducedShares held: Q3 2021 781.2k, Q4 2021 1.6m, Q1 2022 383.2k, Q2 2022 341.2k -42.0k -42,000 -11.0%
80 NANOBIOTIX SPONSORED ADS NBTX NBTX 1,059,800 $4.0m0.13% 0.13% UnchangedShares held: Q3 2021 1.1m, Q4 2021 2.1m, Q1 2022 1.1m, Q2 2022 1.1m
81 QUOTIENT LTD SHS SHS 16,200,818 $3.9m0.12% 0.12% UnchangedShares held: Q3 2021 16.2m, Q4 2021 32.4m, Q1 2022 16.2m, Q2 2022 16.2m
82 ASTRIA THERAPEUTICS INC COM CATB CATB 1,281,197 $3.8m0.12% 0.12% UnchangedShares held: Q3 2021 2.0m, Q4 2021 2.6m, Q1 2022 1.3m, Q2 2022 1.3m
83 PYXIS ONCOLOGY INC COMMON STOCK PYXS PYXS 1,528,812 $3.6m0.11% 0.11% UnchangedShares held: Q3 2021 0, Q4 2021 3.9m, Q1 2022 1.5m, Q2 2022 1.5m
84 MACROGENICS INC COM MGNX MGNX 1,227,202 $3.6m0.11% 0.11% ReducedShares held: Q3 2021 2.1m, Q4 2021 3.3m, Q1 2022 1.6m, Q2 2022 1.2m -332.6k -332,587 -21.3%
85 TYRA BIOSCIENCES INC COM TYRA TYRA 494,403 $3.5m0.11% 0.11% UnchangedShares held: Q3 2021 987.5k, Q4 2021 1.3m, Q1 2022 494.4k, Q2 2022 494.4k
86 CLOVER HEALTH INVESTMENTS CO COM CL A CLOV CLOV 1,500,000 $3.2m0.10% 0.10% UnchangedShares held: Q3 2021 1.5m, Q4 2021 3.0m, Q1 2022 1.5m, Q2 2022 1.5m
87 Y-MABS THERAPEUTICS INC COM YMAB YMAB 212,018 $3.2m0.10% 0.10% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 212.0k
88 SCIENCE 37 HOLDINGS INC COM COM 1,500,000 $3.0m0.09% 0.09% UnchangedShares held: Q3 2021 0, Q4 2021 3.0m, Q1 2022 1.5m, Q2 2022 1.5m
89 ABSCI CORPORATION COM ABSI ABSI 894,346 $3.0m0.09% 0.09% ReducedShares held: Q3 2021 1.5m, Q4 2021 2.8m, Q1 2022 1.2m, Q2 2022 894.3k -296.6k -296,606 -24.9%
90 ENVVENO MEDICAL CORPORATION COM COM 781,615 $3.0m0.09% 0.09% UnchangedShares held: Q3 2021 0, Q4 2021 1.6m, Q1 2022 781.6k, Q2 2022 781.6k
91 FUSION PHARMACEUTICALS INC COM COM 1,052,445 $2.6m0.08% 0.08% ReducedShares held: Q3 2021 1.3m, Q4 2021 2.5m, Q1 2022 1.2m, Q2 2022 1.1m -174.6k -174,572 -14.2%
92 HYPERFINE INC COM CL A HYPR HYPR 1,134,388 $2.5m0.08% 0.08% ReducedShares held: Q3 2021 0, Q4 2021 3.0m, Q1 2022 1.5m, Q2 2022 1.1m -365.6k -365,612 -24.4%
93 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 508,532 $2.4m0.08% 0.08% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 596.9k, Q2 2022 508.5k -88.4k -88,410 -14.8%
94 RELMADA THERAPEUTICS INC COM RLMD RLMD 121,350 $2.3m0.07% 0.07% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 151.3k, Q2 2022 121.3k -30.0k -30,000 -19.8%
95 DARIOHEALTH CORP COM NEW DRIO DRIO 327,869 $2.0m0.06% 0.06% UnchangedShares held: Q3 2021 327.9k, Q4 2021 655.7k, Q1 2022 327.9k, Q2 2022 327.9k
96 FULCRUM THERAPEUTICS INC COM FULC FULC 294,118 $1.4m0.05% 0.05% UnchangedShares held: Q3 2021 294.1k, Q4 2021 588.2k, Q1 2022 294.1k, Q2 2022 294.1k
97 PEAR THERAPEUTICS INC CLASS A COM CLASS A COM 900,548 $1.4m0.04% 0.04% ReducedShares held: Q3 2021 0, Q4 2021 926.2k, Q1 2022 926.2k, Q2 2022 900.5k -25.7k -25,684 -2.8%
98 FERRARI N V COM RACE RACE 6,200 $1.1m0.04% 0.04% UnchangedShares held: Q3 2021 6.2k, Q4 2021 12.4k, Q1 2022 6.2k, Q2 2022 6.2k
99 SONENDO INC COM COM 648,505 $1.1m0.04% 0.04% ReducedShares held: Q3 2021 0, Q4 2021 1.3m, Q1 2022 668.5k, Q2 2022 648.5k -20.0k -20,000 -3.0%
100 ZYMERGEN INC COM ZY ZY 883,332 $1.1m0.03% 0.03% UnchangedShares held: Q3 2021 883.3k, Q4 2021 883.3k, Q1 2022 883.3k, Q2 2022 883.3k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
AGILE THERAPEUTICS INC AGRX AGRX 21,294,485 $178.4m21.3m shares
HORIZON THERAPEUTICS PUB L HZNP HZNP 1,357,903 $142.9m1.4m shares
COLLEGIUM PHARMACEUTICAL INC COLL 2.625 02.15.26 COLL 2.625 02.15.26 9,500,000 $89.5m9.5m shares
NEVRO CORP NVRO NVRO 477,037 $34.5m477.0k shares
PENUMBRA INC PEN PEN 143,591 $31.9m143.6k shares
ZENTALIS PHARMACEUTICALS INC ZNTL ZNTL 501,509 $23.1m501.5k shares
LEGEND BIOTECH CORP LEGN LEGN 616,141 $22.4m616.1k shares
AXONICS INC AXNX AXNX 341,211 $21.4m341.2k shares
PULMONX CORP LUNG LUNG 537,779 $13.3m537.8k shares
ARCUS BIOSCIENCES INC RCUS RCUS 405,000 $12.8m405.0k shares
NANOSTRING TECHNOLOGIES INC NSTG 2.625 03.01.25 NSTG 2.625 03.01.25 1,000,000 $11.0m1.0m shares
CUE HEALTH INC HLTHQ HLTHQ 1,580,607 $10.2m1.6m shares
BCLS ACQUISITION CORP 1,000,000 $9.9m1.0m shares
SUMMIT HEALTHCRE ACQUISTN CO 1,000,000 $9.8m1.0m shares
RESEARCH ALLIANCE CORP II 1,000,000 $9.8m1.0m shares
EVOLENT HEALTH INC EVH EVH 250,000 $8.1m250.0k shares
ACADIA PHARMACEUTICALS INC ACAD ACAD 284,853 $6.9m284.9k shares
ACCOLADE INC ACCD ACCD 330,682 $5.8m330.7k shares
MERUS N V MRUS MRUS 209,046 $5.5m209.0k shares
DA32 LIFE SCNCE TEC ACQSTN C 500,000 $4.9m500.0k shares
SIGHT SCIENCES INC SGHT SGHT 390,000 $4.5m390.0k shares
HEALTH SCIENCES ACQ CORP 2 OBIO OBIO 450,000 $4.5m450.0k shares
INVITAE CORP NVTA NVTA 554,585 $4.4m554.6k shares
IMMUNEERING CORP IMRX IMRX 681,051 $4.4m681.1k shares
INARI MED INC NARI NARI 30,000 $2.7m30.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 100,000 $7.4m100.0k shares New
CASSAVA SCIENCES INC FLNA · Put FLNAPut 100,000 $2.8m100.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.

CompanyTickerStakeChange ScheduleLast filed
ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 ADGM 55.4%≈ $8.8m -2.1 pts 13G 2026-05-15
LEONABIO INC LONA · 13D · filed 2026-10-26 LONA 20.0%≈ $17.4m no change 13D 2026-10-26
LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 LYRA 15.6% 13D 2025-08-14
MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 MGTX 12.6%≈ $158.6m -0.3 pts 13D 2026-04-24
SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 SLDB 11.2%≈ $120.3m -1.7 pts 13D 2026-08-14
PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 FRNM 10.1% new 13G 2026-07-23
INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 INBX 10.0%≈ $141.1m no change 13G 2026-08-14
ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 ANRO 10.0%≈ $110.2m no change 13G 2026-08-14
OPUS GENETICS INC IRD · 13G · filed 2026-08-14 IRD 10.0%≈ $37.6m no change 13G 2026-08-14
ENGENE HOLDINGS INC 13G · filed 2026-08-14 10.0% no change 13G 2026-08-14
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 KPRX 10.0%≈ $1.2m new 13G 2026-08-10
ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 10.0% 13G 2026-02-17
ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 OBIO 10.0%≈ $24.5m 13G 2025-11-14
TRINITY BIOTECH PLC 13D · filed 2026-05-04 9.9% no change 13D 2026-05-04
OUTSET MED INC OM · 13G · filed 2025-02-28 OM 9.5% new 13G 2025-02-28
NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 NAUT 9.1%≈ $21.8m -1.0 pts 13D 2026-08-14
KARDIGAN INC KARD · 13D · filed 2026-10-01 KARD 8.8%≈ $196.9m -0.1 pts 13D 2026-10-01
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 IRLA 8.4%≈ $1.7m new 13G 2026-10-14
RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 RACC 8.2%≈ $8.0m new 13G 2026-05-28
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 XFOR 8.1%≈ $37.8m +0.8 pts 13G 2026-08-14
SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 STRO 7.9%≈ $43.3m +2.5 pts 13G 2026-08-14
PALISADE BIO INC PALI · 13G · filed 2026-05-15 PALI 7.9%≈ $29.5m -2.1 pts 13G 2026-05-15
IMMATICS N.V IMTX · 13D · filed 2026-08-27 IMTX 7.6%≈ $113.5m 13D 2026-08-27
AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 AMLX 7.5%≈ $148.8m -0.7 pts 13G 2026-05-15
SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 SABS 7.3%≈ $25.8m -1.1 pts 13G 2026-08-14

Trades reported as a company insider in Q2 2022

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2022-06-30 LEONABIO INC Director · See Footnote LONA Bought 1,101,362 $3.3m1.1m shares +30%
2022-06-29 LEONABIO INC Director · See Footnote LONA Bought 270,000 $807.3k270.0k shares +8%